Immunology and Microbiology
Severe Acute Respiratory Syndrome Coronavirus 2
100%
Human Immunodeficiency Virus 1
85%
Human Immunodeficiency Virus
74%
Blood Plasma
61%
Viral Load
59%
Omicron Coronavirus Variant
47%
COVID-19
46%
Epstein Barr Virus
40%
Viral Disease
36%
Antibody Response
36%
Virus Infectivity
29%
Vaccine Efficacy
29%
CD4 Lymphocyte Count
26%
Monospecific Antibody
24%
Hepatitis B Virus
24%
Vaccination Policy
20%
Hepatitis C Virus
20%
Spike
19%
T Cell
18%
Inflammatory Arthritis
18%
Coinfection
16%
Cytokine
16%
BK Virus
16%
Real Time Polymerase Chain Reaction
16%
Seroprevalence
15%
Human Immunodeficiency Virus Infection
15%
Neutralization
14%
Breakthrough Infection
14%
Cell Culture
14%
Reverse Transcriptase
14%
Human Immunodeficiency Virus Type 1 Subtype C
13%
Peripheral Blood Mononuclear Cell
13%
Immunosuppression
13%
Toxoplasmosis
12%
Seropositivity
12%
Metagenomic Next-Generation Sequencing
12%
Maturation
12%
Chemokine
12%
Human Cytomegalovirus
12%
Cerebrospinal Fluid
12%
Adaptive Immune System
12%
Autoimmune Disease
12%
Macrophage Inflammatory Protein
12%
Human Herpesvirus 8
12%
JC Virus
12%
Immune Response
12%
Hepatitis C
12%
Immunoassay
12%
Sensitive Detection
12%
Macrophage
12%
Keyphrases
Human Immunodeficiency Virus Type 1 (HIV-1)
92%
Infected Individual
53%
South India
48%
COVID-19
43%
India
41%
Nave
27%
Infectious Virus
24%
Hepatitis B Virus
24%
Pregnant Women
24%
Tertiary Care Hospital
24%
Antibody Response
24%
Epstein-Barr Virus
22%
Healthy Controls
19%
HIV Patients
17%
Viral Kinetics
16%
Unvaccinated
16%
Viral Load
16%
Co-infection
16%
EBNA1
16%
HIV Viral Load
15%
Virus
15%
Plasma Viral Load
15%
Cell Culture
15%
Drug-resistant Variant
14%
Antiretroviral Therapy
13%
Peripheral Blood Mononuclear Cells
13%
CD4 Count
12%
Epstein-Barr Virus Infections
12%
PMTCT
12%
COVID-19 mRNA Vaccine
12%
Gastric Adenocarcinoma
12%
Combivir
12%
Uganda
12%
Healthy Individuals
12%
Antiretroviral Prophylaxis
12%
Neurotropic Virus
12%
Delta Variant
12%
Laboratory Culture
12%
Messenger RNA (mRNA)
12%
SARS-CoV-2 Infection
12%
SARS-CoV-2 Seroprevalence
12%
Replication-competent HIV
12%
HHV-8
12%
Transmitted Drug Resistance mutations
12%
Dried Blood Spots
12%
Organ-specific Autoimmune Diseases
12%
Clinical Laboratory
12%
Blood Donors
12%
HIV Antibodies
12%
Human Liver
12%